Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Putting seizure patients into a medically induced coma may do more harm than good. A new study found that patients with nonconvulsive status epilepticus (NCSE) treated with therapeutic coma had nearly double the in-hospital mortality rate and far higher rates of pneumonia, sepsis, and cardiac complications compared to those managed without it — raising serious questions about when this aggressive intervention is truly warranted.
Medically inducing a coma to stop prolonged seizures — a last-resort strategy for nonconvulsive status epilepticus (NCSE) — may come at a steep price. A new retrospective study of 283 adult NCSE patients treated at a German university hospital found that those who received therapeutic coma faced dramatically worse outcomes across the board compared to those managed without it.
The findings are striking: in-hospital mortality was 43.2% in the therapeutic coma group versus 22.7% in the non-coma group. Patients in the coma group were also far less likely to have their seizures successfully stopped before discharge (70.3% vs. 84.3%). Longer coma duration compounded the risks — every additional 24 hours raised pneumonia odds by 89%.
By the Numbers
Why it matters: These findings challenge the routine use of therapeutic coma in NCSE and call for a more careful weighing of risks and benefits before deploying this aggressive intervention — particularly in older patients who may be most vulnerable to its complications.
